Financhill
Back

Akero Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Buy
61

AKRO
Akero Therapeutics

Last Price:
30.93
Seasonality Move:
8.52%
Sell
18

NBY
NovaBay Pharmaceuticals

Last Price:
0.55
Seasonality Move:
-6.61%
Buy
61
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $30.75. The Score for AKRO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $30.75
    The current trend is moderately bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.28 Buy
Relative Strength Index (14 RSI): 48.02 Sell
Chaikin Money Flow: -206731 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.19 - 33.35) Sell
Bollinger Bands (100): (25.75 - 30.95) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 35.79 Sell
Chaikin Money Flow: -12542 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.63 - 0.75) Sell
Bollinger Bands (100): (0.29 - 1.21) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.74 Sell
20-day SMA: 31.83 Sell
50-day SMA: 30.4 Buy
200-day SMA: 25.68 Buy
8-day EMA: 31.51 Sell
20-day EMA: 31.37 Sell
50-day EMA: 30.31 Buy
200-day EMA: 27.55 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.63 Sell
20-day SMA: 0.68 Sell
50-day SMA: 0.67 Sell
200-day SMA: 2.19 Sell
8-day EMA: 0.62 Sell
20-day EMA: 0.65 Sell
50-day EMA: 0.7 Sell
200-day EMA: 5.28 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):